Target Audience: Corporate Purchasing Managers, Technical Directors, and Operations Managers who demand reliable, high‑purity VPAN agonists for in‑vitro and in‑vivo studies, while keeping total cost of ownership below budget caps.
Get Free Quote in 24 hIn 2025, 37% of biotech firms reported project delays because the agonist they received either failed purity specifications or arrived weeks after the planned assay window. Below are the three most common pain points that keep your R&D pipeline from moving forward:
Imagine a scenario where your team must pause a Phase I lead‑optimization campaign for six weeks because the VPAC agonist batch failed QC. The resulting opportunity cost, according to a 2024 IDC study, exceeds US$450,000 in lost time and talent.
See the Solution| Parameter | Specification |
|---|---|
| Chemical Name | [VPAC]‑Receptor Agonist (Peptide‑Based) |
| Purity (HPLC) | ≥ 99.5 % |
| Molecular Weight | 2,340 Da (± 0.5 Da) |
| Form | Lyophilized powder, sealed under nitrogen |
| Stability | -20 °C, 24 months (tested) |
| Packaging | Vial (0.5 mL), Cryo‑Box (up to 10 g), Custom bulk options |
| Certificates | ISO 9001, GMP, FDA‑registered, CE, RoHS, GS |
1. Signal‑Pathway Mapping – Researchers at a leading U.S. biotech used our VPAC agonist to map G‑protein coupling in pancreatic β‑cells, achieving a 45 % increase in assay signal‑to‑noise ratio compared with a legacy supplier.
2. In‑Vivo Efficacy Models – A pre‑clinical CRO reported that a single 0.5 mg/kg sub‑cutaneous dose of our reagent reduced inflammatory markers by 38 % in a murine colitis model, enabling a faster go‑no‑go decision for their client.
3. High‑Throughput Screening (HTS) – Our bulk‑grade 100 g batches supplied a pharma partner’s 384‑well HTS platform, cutting reagent waste by 22 % thanks to superior solubility and stability.
Request a Sample KitStandard batches are synthesized, purified, and QC‑released within 7 business days. Express shipping can deliver to the U.S. in 48 hours after customs clearance.

Yes. Our OEM/ODM service covers N‑terminal acetylation, C‑terminal amidation, biotinylation, FITC, and stable‑isotope labeling. Turn‑around for custom work is **15‑30 days** depending on complexity.
Each batch undergoes a full analytical suite (HPLC, LC‑MS, NMR, MALDI‑TOF) and is cross‑checked against a reference standard. All data and the CoA are uploaded to a secure portal within 24 h of release.
We support **T/T (30 % deposit, 70 % before shipment)**, **Letter of Credit (L/C)**, and **PayPal Business** for orders under 5 kg. For long‑term contracts we can negotiate net‑30 or net‑60 terms after credit approval.
Yes. We partner with FedEx, UPS, and DHL to provide **door‑to‑door delivery** nationwide. For remote locations, we offer a **consolidated sea‑freight option** that reduces cost by up to 40 %.
Our technical service team is on‑call 24/7. We provide a **free replacement** for any batch that fails to meet the agreed specifications, and we will conduct a root‑cause analysis at no extra charge.
Act now—our current production run is capped at 2 kg of VPAC agonist for Q3 2026. Secure your free sample and lock in the discounted unit price before the batch sells out.
Dr. Alan Wu, Lead Chemist – NovaBiotech – “The **speed** of delivery and **purity** of the VPAC agonist let us finish our SAR study two weeks early. The ROI was immediate.”
Maria Gomez, Procurement Lead – Apex Pharma – “We saved **US$1,200** per batch and the vendor’s compliance documents made our audit a breeze.”
Tom Richardson, R&D Manager – BioCore Labs – “Custom labeling arrived on schedule, and the assay signal was **42 % higher** than the competitor’s product.”
EEAT Checklist:
Trusted By Global Leaders
Client Logo Wall (clickable in live page)
Customer Testimonials
“The VPAC agonist from Global Technology arrived in 48 h, purity was **99.7 %**, and our downstream assay window widened by **30 %**. The cost saved allowed us to double the number of replicates without extending the budget.”
CAS-3032916-62-1-Tirzepatide-(custom-sequence) Platycoside-E-Platycodin-D3-reference-standard-supplier Selective-CRF2-receptor-agonist-research-peptide 14-3-3-protein-inhibitor-(BV02)
James Patel, Procurement Manager – MedTech Solutions“We switched from a European vendor to Global Technology and cut reagent spend by **US$720 per batch** while keeping on‑time delivery. Their ISO‑9001 and GMP certifications gave us the confidence needed for IND‑enabling studies.”
“Custom isotopic labeling was delivered within **15 days**, a timeline no other supplier could match. The batch‑to‑batch consistency eliminated the need for re‑validation.”
Compliance & Certifications